USFDA approves OxyContin for children aged 11 to 16

Published On 2015-08-15 07:04 GMT   |   Update On 2015-08-15 07:04 GMT
USFDA has approved OxyContin, a narcotic painkiller for children aged 11 to 16. The approval has been received with mixed response, with doctors treating young cancer patients hailing the use of opioid, while others doubting the use of drug on children fearing addiction.

OxyContin is an extended-release opioid that has long been used to treat around-the-clock pain in adults. But most pain medications are not approved for use in children.

The FDA says it asked drugmaker Purdue Pharma to study how to safely use OxyContin in children.

Under the approval announced Thursday, prescribers are directed to only prescribe OxyContin to children who can already tolerate another opioid. Taking a sudden dose of an opioid can lead to overdose and death if patients haven't previously been exposed to the drugs.

The FDA notes that the Duragesic patch is the only other opioid approved for children.

 
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News